Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Exavir Therapeutics Inc.

Headquarters: Omaha, NE, United States of America
Year Founded: 2021
Status: Private

BioCentury | Dec 23, 2022
Discovery & Translation

Enhancer elements for tissue regeneration; plus Alentis’ mAb for fibrosis and more

BioCentury’s roundup of translational news
BioCentury | Sep 16, 2022
Finance

Sept. 15 Quick Takes: Khosla seeds Cas13 company Carver

Plus RGImmune launches with F-Prime’s backing and updates from Pfizer, Tridek-One  
BioCentury | Jun 17, 2022
Discovery & Translation

Scalable method to measure SARS-CoV-2 T cell immunity; plus therapies from NeoImmune, Exavir and more

BioCentury’s roundup of translational news
Items per page:
1 - 3 of 3